drugset / Trial / NCT01158417
Resveratrol in Type2 Diabetes and Obesity
RandomizedParallel-groupSingle-blindTreatment
Summary
The main objective of this study is to investigate the effect of resveratrol (plant derived food supplement) on inflammatory mediators and insulin resistance at the cellular and molecular level in obese non diabetic and type 2 diabetic subjects in vivo.
Timeline
- Start
- 2008-12
- Primary completion
- 2012-07-08
- Completion
- 2012-07-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Resveratrol | Small molecule | 40 mg | Oral |
| Subject | Resveratrol | Small molecule | 500 mg | Oral |